Pharma

DIA has been the world’s leading member-based, non-profit organization driving innovation in patient safety and outcomes. We attract thousands of leading international life sciences organizations from Pharma, Biotech, Medical Device, and Diagnostic Equipment together with global regulatory agencies and leading academic researchers in a neutral, collaborative environment.

The Canada Annual Meeting will deliver a comprehensive overview of the current biopharma and device landscape in Canada, while sharing insights into Canada’s broader role in global healthcare product development. From policy updates and priorities shared directly from Health Canada, to sessions on international work sharing and partnerships, to key regulatory, clinical, and safety considerations for drugs and devices, you will have the exclusive opportunity to address the current issues and opportunities in Canada and across the globe.

Discovery on Target (DOT) highlights advances in current and emerging “hot” targets and technologies, as well as target validation strategies for the discovery and development of novel therapeutic agents ranging from biologics to small molecules.

Our unparalleled annual gathering of the leading innovators, investors, payers, providers and policymakers who are driving the digital health revolution.

Join other leading innovators, investors, payers, providers, and policymakers as we continue to help revolutionize healthcare by discussing the most pertinent topics to the field.

BIO attracts leading biotechs, top 25 pharma, top 20 CROs and CMOs and major research labs and government agencies. The BIO International Convention (BIO) attracts 16,000+ biotechnology and pharma leaders who come together for one week of intensive networking to discover new opportunities and promising partnerships. The conference brings together a wide spectrum of life science and application areas including drug discovery, biomanufacturing, genomics, biofuels, nanotechnology and cell therapy.

Baird is delighted to host its annual Global Healthcare Conference. This conference brings institutional and private equity investors together with senior management from over 90 public and privately-held companies. The conference will feature companies across the following sectors: Biotechnology, Healthcare Supply Chain & Pharma Services, Healthcare Information Technology, Life Sciences & Diagnostics, Medical Technology and Facilities & Services. 

Australia’s largest biotech event. Partnering opportunities for industry and investments. *** Early stage companies attendance component.

The ATS International Conference is the home of pulmonary, critical care, and sleep professionals, from those in the earliest stages of their careers to those whose research or strides in clinical care has gained them international recognition. Each year, nearly 14,000 of these professionals choose to attend, present, and learn about the latest advances, meet with colleagues from around the world, and strike new collaborations. It is truly where today’s science meets tomorrow’s care.

Join ASN for Kidney Week, the world’s premier nephrology meeting. More than 13,000 kidney professionals from around the globe will come together to exchange knowledge, learn the latest scientific and medical advances, and listen to engaging and provocative exchanges between leading experts in the field.